Richmond Afful

Richmond Afful is a Biology major with a minor in Mathematics at New York University Abu Dhabi, with interests in biochemistry, structural biology, and therapeutic development. He joined the lab in 2024, contributing to research on human hexokinase-2, an enzyme involved in glucose metabolism and implicated in cancer progression, and the SARS-CoV-2 main protease (3CLpro). Through these projects, he has gained hands-on experience in protein expression, purification, and biophysical characterization.

For his capstone project, Richmond is investigating the SARS-CoV-2 papain-like protease (PLpro), focusing on how specific amino acid residues influence its catalytic activity and structural stability, to identify potential targets for antiviral drug development. He aspires to pursue graduate studies and further explore the molecular mechanisms underlying human disease and their implications for therapeutic development.

Back to people